DR info

Clinical trials : 11 / Drugs : 15 - (DrugBank : 2) / Drug target genes : 4 - Drug target pathways : 9

Progressive myoclonus epilepsy and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
309	Progressive myoclonus epilepsy	-
6	Parkinson disease	4.000
2	Amyotrophic lateral sclerosis	4.000
4	Primary lateral sclerosis	4.000
7	Corticobasal degeneration	2.500
74	Prolactin secreting pituitary adenoma	2.391
20	Adrenoleukodystrophy	2.352
201	Angelman syndrome	2.352
164	Oculocutaneous albinism	2.316
140	Dorabe syndrome	2.297
90	Retinitis pigmentosa	2.296
17	Multiple system atrophy	2.287
8	Huntington disease	2.277
299	Cystic fibrosis	2.273
86	Pulmonary arterial hypertension	2.272
206	Fragile X syndrome	1.037
13	Multiple sclerosis/Neuromyelitis optica	1.008